The authors declare that this study is associated with no significant financial and non-financial interests that may account for the perception of conflict of interest or its potential thereof.
Ethical approval
This study employed publicly available, de-identified data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program. This study was therefore exempt from review by an institutional review board (IRB).
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Availability of data and materials
The datasets that support the findings of this study are available from the corresponding author upon reasonable request.
Funding
This work was supported by the National Natural Science Foundation of China [82173899]; the Jiangsu Pharmaceutical Association [H202108, A2021024, Q202202, JY202207, Z04JKM2023E040], Top Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project [2022CZBJ04]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.Cancer Commun. 2021;41:1183–94. [DOI] [PubMed] [PMC]
Elbasheer MMA, Dodwell D, Gathani T. Understanding global variation in breast cancer mortality.Br J Radiol. 2025;98:1369–72. [DOI] [PubMed] [PMC]
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021.CA: Cancer J Clin. 2021;71:7–33. [DOI] [PubMed]
Gon Y, Zha L, Morishima T, Kimura Y, Asai K, Kudo H, et al. Non-cancer-related Deaths in Cancer Survivors: A Nationwide Population-based Study in Japan.J Epidemiol. 2025;35:147–53. [DOI] [PubMed] [PMC]
Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, et al. Causes of death among cancer patients.Ann Oncol. 2017;28:400–7. [DOI] [PubMed] [PMC]
Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.Lancet. 2021;397:2385–438. [DOI] [PubMed]
Coughlin SS, Ayyala D, Majeed B, Cortes L, Kapuku G. Cardiovascular Disease among Breast Cancer Survivors.Cardiovasc Disord Med. 2020;2:10.31487/j.cdm.2020.01.01. [DOI] [PubMed] [PMC]
Koric A, Chang CP, Mark B, Rowe K, Snyder J, Dodson M, et al. Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study.Cancer. 2022;128:2826–35. [DOI] [PubMed] [PMC]
Obeidat O, Charles KR, Akhter N, Tong A. Social Risk Factors That Increase Cardiovascular and Breast Cancer Risk.Curr Cardiol Rep. 2023;25:1269–80. [DOI] [PubMed] [PMC]
Kirkham AA, Beaudry RI, Paterson DI, Mackey JR, Haykowsky MJ. Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer.Prog Cardiovasc Dis. 2019;62:116–26. [DOI] [PubMed]
Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, et al. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.J Natl Cancer Inst. 2020;113:137–45. [DOI] [PubMed] [PMC]
Haque M, Atallah N, Patke R, Harris AE, Woodcock CL, Varun D, et al. Cardiotoxicity of breast cancer drug treatments.Transl Oncol. 2025;55:102352. [DOI] [PubMed] [PMC]
Padegimas A, Clasen S, Ky B. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.Trends Cardiovasc Med. 2020;30:22–8. [DOI] [PubMed] [PMC]
Lanza O, Ferrera A, Reale S, Solfanelli G, Petrungaro M, Tini Melato G, et al. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies.Med Sci. 2022;10:27. [DOI] [PubMed] [PMC]
Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients.Eur Heart J. 2019;40:3889–97. [DOI] [PubMed] [PMC]
Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Bhaskaran K, et al. Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study.J Natl Compr Cancer Netw. 2021;19:275–84. [DOI] [PubMed]
National Cancer Institute. Surveillance, Epidemiology, and End Results Program [Internet].[cited 2025 Oct 3]. Available from: https://seer.cancer.gov
Friede A, Reid JA, Ory HW. CDC WONDER: a comprehensive on-line public health information system of the Centers for Disease Control and Prevention.Am J Public Health. 1993;83:1289–94. [DOI] [PubMed] [PMC]
Nelson DR, Brown J, Morikawa A, Method M. Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.PLOS ONE. 2022;17:e0264637. [DOI] [PubMed] [PMC]
Woodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, et al. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022.Am J Prev Med. 2024;66:582–9. [DOI] [PubMed] [PMC]
Ury HK, Wiggins AD. Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio).Am J Epidemiol. 1985;122:197–8. [DOI] [PubMed]
Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis.J Clin Epidemiol. 1996;49:907–16. [DOI] [PubMed]
Ng HS, Meng R, Marin TS, Damarell RA, Buckley E, Selvanayagam JB, et al. Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta-analysis.Cancer Med. 2024;13:e70057. [DOI] [PubMed] [PMC]
Yeo YH, San BJ, Tan JY, Tan MC, Donisan T, Lee JZ, et al. Cardiovascular mortality trends and disparities in U.S. breast cancer patients, 1999-2020: a population-based retrospective study.Cardiooncology. 2024;10:89. [DOI] [PubMed] [PMC]
Hamczyk MR, Nevado RM, Barettino A, Fuster V, Andrés V. Biological Versus Chronological Aging.J Am Coll Cardiol. 2020;75:919–30. [DOI] [PubMed]
Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Horne FM, et al. Multimorbidity in Older Adults With Cardiovascular Disease.J Am Coll Cardiol. 2018;71:2149–61. [DOI] [PubMed] [PMC]
Vo JB, Ramin C, Veiga LHS, Brandt C, Curtis RE, Bodelon C, et al. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.JNCI: J Natl Cancer Inst. 2024;116:1384–94. [DOI] [PubMed] [PMC]
Vo JB, Ramin C, Lawrence WR, Barac A, Ho KL, Rhee J, et al. Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors.JNCI Cancer Spectr. 2023;7:pkad024. [DOI] [PubMed] [PMC]
Sutton AL, Felix AS, Wahl S, Franco RL, Leicht Z, Williams KP, et al. Racial disparities in treatment-related cardiovascular toxicities amongst women with breast cancer: a scoping review.J Cancer Surviv. 2023;17:1596–605. [DOI] [PubMed]
Ho KL, Shiels MS, Ramin C, Veiga LHS, Chen Y, Berrington de Gonzalez A, et al. County-level geographic disparities in cardiovascular disease mortality among US breast cancer survivors, 2000-2018.JNCI Cancer Spectr. 2023;7:pkac083. [DOI] [PubMed] [PMC]
Guan T, Wang Y, Li F, Chen D, Wei Q, Wang K, et al. Association of marital status with cardiovascular outcome in patients with breast cancer.J Thorac Dis. 2022;14:841–50. [DOI] [PubMed] [PMC]
Manfredini R, De Giorgi A, Tiseo R, Boari B, Cappadona R, Salmi R, et al. Marital Status, Cardiovascular Diseases, and Cardiovascular Risk Factors: A Review of the Evidence.J Womens Health (Larchmt). 2017;26:624–32. [DOI] [PubMed]
Jarada TN, O’Sullivan DE, Brenner DR, Cheung WY, Boyne DJ. Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer.Curr Oncol. 2023;30:1945–53. [DOI] [PubMed] [PMC]
Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms.Nat Rev Cardiol. 2024;21:617–31. [DOI] [PubMed] [PMC]
Gent DG, Rebecca D. The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus.Eur Cardiol Rev. 2023;18:e16. [DOI] [PubMed] [PMC]
